MOURA DUBEUX (MDNE3) Main Indicators
Basic Data - MDNE3
| Company | MOURA DUBEUX |
| Corporate Name | MOURA DUBEUX ENGENHARIA S/A |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Compra e venda de imóveis. locação. desmembramento ou loteamento de terrenos. incorporação imobiliária ou construção de imóveis destinados à venda. participação em outras sociedades. |
| Share | MDNE3 |
| Quote Date | 12/02/2024 |
| Share Type | ON |
| Last Closing | R$ 12.10 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 18.49 M |
| Last Statement | ITR - 09/30/2024 |
| Sector | Consumo Cíclico |
| Subsector | Construção Civil |
| Segment | Incorporações |
| Participation Indexes | GPTW, IBRA, ICON, IGC, IGCT, IGNM, IMOB, ITAG, SMLL |
| Updated 12/03/2024 | |
Relative Prices - MDNE3
| Price/Earnings | 4.28 |
| Price/SBV | 0.66 |
| Price/Net Sales | 0.69 |
| Price/CFO | -13.70 |
| Price/FCF | -10.27 |
| Price/Total Assets | 0.26 |
| Price/EBIT | 4.24 |
| Price/Working Capital | 0.88 |
| Price/NCAV | -0.81 |
| EV/EBIT | 4.91 |
| EV/EBITDA | 4.71 |
| EV/Net Sales | 0.80 |
| EV/CFO | -15.87 |
| EV/FCF | -11.90 |
| EV/Total Assets | 0.30 |
| Company Market Cap | R$ 1.03 B |
| Enterprise Value | R$ 1.19 B |
| Current Financial Statement Date | 09/30/2024 |
| Current Share Price | R$ 12.10 |
| Share Price Date | 12/02/2024 |
| Dividend Yield | 5.37% |
| Updated 12/03/2024 | |
Income Statement - MDNE3
| Net Revenue | R$ 1.49 B |
| Gross Result | R$ 511.44 M |
| EBIT | R$ 242.50 M |
| Depreciation and Amortization | - R$ 10.18 M |
| EBITDA | R$ 252.68 M |
| Net Profit | R$ 240.16 M |
| Net Profit/Share | R$ 2.83 |
| Updated 11/07/2024 | |
| Net Revenue | R$ 501.75 M |
| Gross Result | R$ 166.09 M |
| EBIT | R$ 82.86 M |
| Depreciation and Amortization | - R$ 2.44 M |
| EBITDA | R$ 85.30 M |
| Net Profit | R$ 89.16 M |
| Profit/Share | R$ 1.05 |
| Updated 11/07/2024 | |
Price and Volume Behavior - MDNE3
| Lowest Price 52 weeks | R$ 9.72 |
| Highest Price 52 weeks | R$ 15.94 |
| Variation 2024 | -1.58% |
| Variation 1 year | 3.42% |
| Variation 2 years(total) | 112.94% |
| Variation 2 years(yearly) | 45.85% |
| Variation 3 years(total) | 176.31% |
| Variation 3 years(yearly) | 40.28% |
| Variation 4 years(total) | 19.47% |
| Variation 4 years(yearly) | 4.54% |
| Variation 5 years(total) | - |
| Variation 5 years(yearly) | - |
| Average Daily Volume (3 months) | R$ 9.50 M |
| Updated 12/03/2024 | |
Returns and Margins - MDNE3
| Return on Initial Tangible Capital | 6.00% |
| Return on Initial Invested Capital | 11.65% |
| Pre-Tax Return on Initial Tangible Capital | 9.09% |
| Pre-Tax Return on Initial Invested Capital | 17.65% |
| Return on Initial Shareholder´s Equity | 18.38% |
| Return on Initial Asset | 7.39% |
| Gross Margin | 34.44% |
| Net Margin | 16.17% |
| EBIT Margin | 16.33% |
| EBITDA Margin | 17.01% |
| Initial Asset Turnover | 0.46 |
| Financial Leverage | 2.56 |
| Liabilities/Net Worth | 1.56 |
| Net Debt/EBITDA | 0.64 |
| Updated 11/07/2024 | |
Balance Sheet - MDNE3
| Cash and Cash Equivalents | R$ 316.87 M |
| Total Assets | R$ 3.98 B |
| Short-Term Debt | R$ 3.67 M |
| Long-Term Debt | R$ 476.02 M |
| Gross Debt | R$ 479.69 M |
| Net Debt | R$ 162.82 M |
| Shareholder´s Equity | R$ 1.55 B |
| Share Book Value | R$ 18.30 |
| Common Shares | 84,909,375 |
| Preferred Shares | 0 |
| Total | 84,909,375 |
| Common Shares in Treasury | 690,396 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 690,396 |
| Common Shares (Except Treasury) | 84,218,979 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 84,218,979 |
| Updated 11/07/2024 | |
Cash Flow - MDNE3
| Operating Cash Flow | - R$ 75.00 M |
| Cash Flow from Investments | - R$ 37.67 M |
| Financing Cash Flow | R$ 254.91 M |
| Increase (Reduction) in Cash and Equivalents | R$ 142.24 M |
| Updated 11/07/2024 | |
| Operating Cash Flow | R$ 22.17 M |
| Cash Flow from Investments | - R$ 76.95 M |
| Financing Cash Flow | R$ 156.84 M |
| Increase (Reduction) in Cash and Equivalents | R$ 102.06 M |
| Updated 11/07/2024 | |
Experimental - MDNE3
| CAPEX 3 months | - R$ 3.71 M |
| Free Cash Flow 3 months | R$ 18.47 M |
| CAPEX 12 months | - R$ 25.05 M |
| Free Cash Flow 12 months | - R$ 100.04 M |
| Updated 11/07/2024 | |